[Comparison of four domestic quantity assay reagents for detecting the weak-reactive results of HBsAg]

Ling-Li Jiang1, Hui-Ying Chen, Yan-Qun Xiao

  • 1Shanghai Centre for Clinical Laboratory, Shanghai 200126, China.

Insights

This study compared four domestic hepatitis B surface antigen (HBsAg) assay reagents against the ARCHITECTi2000 immunoassay system. Domestic reagents showed lower sensitivity, particularly for weak-reactive samples, but higher agreement for samples with higher HBsAg concentrations.

Area of Science:

  • Clinical Chemistry
  • Immunoassay Technology
  • Hepatitis B Diagnostics

Context:

  • The ARCHITECTi2000 immunoassay system is a widely used platform for various diagnostic tests.
  • Evaluating the performance of domestic diagnostic reagents is crucial for healthcare accessibility and cost-effectiveness.
  • Hepatitis B surface antigen (HBsAg) testing is a primary method for diagnosing Hepatitis B virus infection.

Purpose:

  • To assess the coincidence and correlation between four domestic HBsAg quantitative assay reagents and the ARCHITECTi2000 immunoassay system.
  • To analyze the precision and agreement of these assays across different concentration levels of HBsAg.
  • To compare the analytical sensitivity of domestic reagents with a commercial benchmark system.

Summary:

  • 185 weak-reactive serum samples and standards were tested. Coincidence rates varied significantly, with domestic assays showing lower agreement (18.52%-51.85%) for low concentrations (0.05-1.00 IU/ml) compared to the ARCHITECTi2000.
  • For higher concentrations (>1.00-10.00 IU/ml), coincidence rates improved for domestic assays (69.47%-95.42%).
  • Domestic assays demonstrated lower analytical sensitivity than the ARCHITECTi2000, with notable discrepancies for samples below 0.80 IU/ml, while samples above 7.93 IU/ml showed high consistency.

Impact:

  • Domestic HBsAg assay reagents exhibit performance limitations, especially in detecting low-level reactivity, compared to the ARCHITECTi2000 system.
  • These findings highlight the need for further development of domestic reagents to enhance sensitivity and consistency across all clinically relevant concentration ranges.
  • The study provides valuable data for laboratories considering the adoption of domestic HBsAg testing solutions, informing decisions based on performance characteristics and intended use.

Related Concept Videos